Paper Details

  1. Home
  2. Paper Details

Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design.

Author: BöhlerS, FigullaH R, SaubaduS, ScheldewaertR

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Beta-blockers were previously thought to be contraindicated in heart failure due to their negative inotropic effects. However, there is growing evidence that beta-blockers may slow down the progression of heart failure. BETACAR is a comparative study investigating the benefits of beta-blockade with betaxolol versus carvedilol in chronic heart failure.
Paper Details　
Original Abstract of the Article :
The use of beta-blockers in heart failure for a long time was regarded as contra-indicated because of their negative inotropic effects. Nevertheless, there is growing evidence that beta-blockers slow down the progression of left ventricular dilatation that characterizes heart failure. In addition ch...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1055/s-0031-1300420

データ提供：米国国立医学図書館（NLM）

Betaxolol vs. Carvedilol in Heart Failure: A Comparative Study

The heart is a vital organ, a tireless pump that sustains life. When the heart weakens, as in the case of heart failure, individuals face significant challenges. This study examines the potential benefits of beta-blockers, a class of medications that block the effects of adrenaline, in the treatment of chronic heart failure (CHF). The authors designed a comparative study to evaluate the efficacy of betaxolol, a highly selective beta-blocker, versus carvedilol, a non-selective beta-blocker, in CHF patients.

A Comparative Journey: Exploring Beta-Blocker Efficacy in Heart Failure

This study provides valuable insights into the potential benefits of beta-blockers in managing CHF. By comparing the effects of betaxolol and carvedilol, the study aims to shed light on the optimal beta-blocker treatment for CHF patients.

Strengthening the Heart: A Desert Oasis of Cardiovascular Health

Heart failure is a serious condition that can significantly impact quality of life. This study highlights the importance of investigating effective treatment options for CHF, such as beta-blockers, to improve patient outcomes and enhance cardiovascular health.

Dr.Camel's Conclusion

The desert of heart failure can be a treacherous landscape, but with the right treatments and care, we can help individuals navigate this journey and restore strength to their hearts.

Date :
  1. Date Completed 1999-07-08
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

10337449

DOI: Digital Object Identifier

10.1055/s-0031-1300420

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.